Company: SNWV
Filing Date: 2025-03-07
Form Type: 8-K
Source: 0001628280-25-011275
Chunk: 3

Company: SANUWAVE Health, Inc.
Filing Date: 2025-03-07
Form: 8-K
Item: Item 8.01
Chunk 3
---
Item 8.01 Other Events.

On March 3, 2025, the Company received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC approving the Uplisting. The Company expects its Common Stock will begin trading on Nasdaq on March7, 2025 under the ticker symbol “ SNWV.”

Forward-Looking Statements

This Current Report on Form 8-K may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to the expected timing of the Uplisting, future financial results, production expectations, and plans for future business development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the key risks, assumptions and factors that may affect operating results, performance and financial condition are risks associated with regulatory oversight, the Company’s ability to manage its capital resources, competition, and the other factors discussed in detail in

the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statement.

Item 9.01 Financial Statements and Exhibits.